We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GDS market cap is 1.46B. The company's latest EPS is EUR -0.4884 and P/E is -27.13.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.99B | 4.38B | 4.64B | 4.94B | 5.01B |
| Operating Income | 231.6M | 274.3M | 283.8M | 218M | 160.6M |
| Net Income | 13.4M | 65M | 118.4M | 49.4M | -53.9M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 6.71B | 6.68B | 6.79B | 6.96B | 6.9B |
| Total Liabilities | 5.68B | 5.58B | 5.55B | 5.68B | 5.67B |
| Total Equity | 1.04B | 1.1B | 1.24B | 1.28B | 1.23B |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 729.6M | 652.3M | 262.5M | 598.9M | 586.8M |
| Investing | -186.2M | -181.4M | -471.1M | -175.4M | -180.5M |
| Financing | -377.2M | -390.6M | -264.2M | -197.1M | -401.5M |
| Market Cap | 1.46B |
| Price to Earnings Ratio | -27.13 |
| Price to Sales Ratio | 0.29 |
| Price to Cash Ratio | 4.07 |
| Price to Book Ratio | 1.19 |
| Dividend Yield | - |
| Shares Outstanding | 110.37M |
| Average Volume (1 week) | 152 |
| Average Volume (1 Month) | 893 |
| 52 Week Change | -33.42% |
| 52 Week High | 20.80 |
| 52 Week Low | 11.40 |
| Spread (Intraday) | 0.05 (0.38%) |
| Company Name | Ramsay Generale De Sante |
| Address |
39 rue mstislav rostropovitch paris, paris 75017 |
| Website | https://www.ramsaygds.fr |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
